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Dopamine modulates a range of behaviors that include motor processes, learning, and incentive 
motivation. Neuroanatomical research supports conservation of dopaminergic populations in the 
midbrain across vertebrate species, however, less evidence is available for dopamine receptor 
distributions and function. In order to test the behavioral role of dopamine in a conserved 
dopaminergic system, the effects of D2-type receptor manipulation on motor behaviors were 
examined in the anuran amphibian green tree frog, Hyla cinerea. In two different experiments, 
frogs were treated with a D2 receptor-specific drug, quinpirole or haloperidol, and exposed to a 
testing session to measure changes in motor behaviors. Quinpirole generally inhibited some 
motor behaviors, while haloperidol generally stimulated some motor behaviors, as predicted 
based on receptor mechanisms. A pattern of performance improvement also appeared in frogs in 
each experiment. Overall, the results support general conservation of DA in motor processes in 
vertebrate species. 
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1 INTRODUCTION 
Dopamine (DA) is a catecholaminergic neurotransmitter important for the modulation of 
processes in peripheral and central nervous systems of both vertebrate and invertebrate 
organisms (Yamamoto and Vernier, 2011). While a large amount of evidence points toward 
conservation of the DA neuroanatomical systems in vertebrates, notably in the basal ganglia 
nuclei (Smeets, 1995) (Reiner et al., 1998) (Maier et al., 2010) (Yamamoto and Vernier, 2011) 
(Callier et al., 2003), evidence also supports conservation for the influence of these systems in 
behavior. One challenge of interpreting the behavioral role of DA comes from the variation in 
behaviors that are exhibited by different organisms and modulated by the DA systems. However, 
it is possible to generalize behaviors across species into categories that include 1.) motor 
processes, 2.) social behaviors, and 3.) goal-directed behaviors. For example, singing behavior 
expressed by male songbirds is modulated by dopaminergic activity in the song and motor nuclei 
of the avian brain (Hara et al., 2007), and sexual behaviors in rats can be modified depending on 
the type of manipulation to the DA systems (reviewed by Hull et al., 2004). Because a vast 
amount of mammalian and avian data support a significant role for DA in motor processes, as 
well as goal-directed and social behaviors, a question arises that asks- How do DA processes in 
behavior compare across an evolutionary scale to simpler DA systems, such as those found in the 
anuran amphibian green tree frog, Hyla cinerea? In an attempt to answer this question, we first 
need to identify the evolutionary characteristics of structure and function across vertebrate DA 
systems, and determine how these comparisons relate to species-specific, as well as general, 
behaviors. To do so, we will review the conserved mechanisms of catecholamine synthesis and 
receptor processes, as well as receptor localization and functional networks. Finally, we will 
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consider how all these factors result in behavioral output through a motor test focused on DA 
receptor-specific manipulation on H. cinerea.  
 
1.1 Tyrosine hydroxylase distribution 
In support of physiological conservation of DA systems in vertebrates, catecholaminergic cell 
populations and projections to the basal ganglia have been identified by tyrosine hydroxylase 
(TH) immunohistochemical labeling in anuran neural tissue. TH is the rate-limiting enzyme for 
catecholamine synthesis, and labeling cells that use it is a common way to identify populations 
that produce dopamine, noradrenaline or adrenaline, based the presence or absence of other 
specific enzymes (ex. dopamine-β hydroxylase, phenylethanolamine N-methyltransferase) or 
neurotransmitters (DA and noradrenaline) (Gonzalez, 1994). Notably, the anuran TH-ir 
populations are comparable to some extent to avian and mammalian systems (Marin et al., 
1997a). As in amniotes (reptiles, birds, and mammals), midbrain populations in anurans serve as 
the source of DA to the striatal regions, and there is a general pattern in TH-ir distribution across 
anuran species (Creighton, 2009) (Gonzalez and Smeets, 1991) (Gonzalez et al., 1993). In the 
amniote midbrain, TH-ir neurons are generally located in the substantia nigra (A9; SN) and 
ventral tegmental area (A10; VTA); SN neurons project to the dorsal striatum to form the 
nigrastriatal pathway, and VTA neurons project to the nucleus accumbens (NAc) to form the 
mesolimbic pathway (Yamamoto and Vernier, 2011). In the anuran midbrain, TH-ir neurons are 
distributed on a rostral-caudal plane through the posterior tuberculum and midbrain tegmentum 
(Marin et al., 1997a). While the anuran TH-ir neurons project to the striatum, there is less 
specificity in the terminal destination of the projections in the basal ganglia (Smeets, 1995) 
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(Reiner et al., 1998) (Marin et al., 1997a). However, the anuran midbrain exhibits stronger 
projections to the NAc than the striatum (Gonzalez, 1994) (Marin et al., 1998b). 
 
1.2 Characteristics of DA receptors 
Neurons are dependent on neurotransmitter receptors to initiate cell response to incoming signals 
by neurotransmitter binding. At least seven different DA receptor subtypes have been identified 
in vertebrate neural tissue (Yamamoto and Vernier, 2011). The different DA receptor subtypes 
are highly conserved in structure and function across vertebrates and invertebrates (Callier et al., 
2003) (Yamamoto and Vernier, 2011) (Mustard et al., 2005). In general, all DA receptors are 
metabotropic, and can be categorized into two groups based on activation of adenylate cyclase 
(AC) upon binding (Beaulieu and Gainetdinov, 2011). D1-type receptors (referred to henceforth 
as D1 receptors; including subtypes D1/1A, D5/1B, D1C, and D1D) are coupled to Gs proteins, 
function post-synaptically, and activate AC to promote generation of EPSP. D2-type receptors 
(referred to henceforth as D2 receptors; including subtypes D2, D3, and D4) are coupled to Gi 
proteins, function as autoreceptors and post-synaptically, inhibit AC, and initiate other processes 
that block either neurotransmitter release or the generation of EPSP, depending on location 
(Beaulieu and Gainetdinov, 2011) (Kebabian and Calne, 1979). Although mammals show five 
DA receptor subtypes, birds and anurans show six, but differ in one D1 receptor subtype 
(Yamamoto and Vernier, 2011). Functionally, D1 receptor activation increases cell excitability, 
while D2 receptor activation decreases cell excitability, in medium spiny neurons in both avian 
(Ding and Perkel, 2002) and mammalian (Nicola et al., 2000) basal ganglia tissue.  
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Although DA receptors have not yet been localized in anuran neural tissue, general similarities in 
receptor localization in other vertebrate neural tissue support conservation of receptor 
localization. Generally in the rat brain, DA receptors are located in the midbrain and at the 
terminal destinations of midbrain axons in the basal ganglia and forebrain regions. The dorsal 
striatum, nucleus accumbens, and olfactory tubercle show high levels of D1 receptors, while the 
hippocampus, cortex, thalamus, and hypothalamus express D1 receptors at lower levels 
(Palermo-Neto, 1997). D2 receptors are also found at high levels in the dorsal striatum, nucleus 
accumbens, olfactory tubercle, as well as the globus pallidus, periaqueductal gray, amygdala, 
cortex, substantia nigra, ventral tegmental area, and medulla (Palermo-Neto, 1997). Similar DA 
receptor localization patterns are found in birds (Kubikova et al., 2010). 
 
While the same general neural regions express DA receptors across vertebrates, different classes 
show unique characteristics for receptor quantification. In particular, adult mammals have 
approximately twice as many D1 receptors compared to D2 receptors, while adult birds and 
turtles show the opposite with more D2 receptors in the basal ganglia (Richfield et al., 1987). 
This difference was supported more recently, when Kleitz et al. demonstrated a greater D2:D1 
receptor ratio in quail neural tissue compared to rat neural tissue (Kleitz et al., 2009). However, 
autoradiographic labeling on anuran neural tissue tends to exhibit a ratio of DA receptors similar 
to mammals, i.e. more D1 receptors than D2 receptors, and similar, although not identical, 
receptor affinities to DA receptor-specific drugs between anuran and mammalian tissue samples 
(Chu et al., 2001). It is noted that all these comparisons are made on tissue samples collected 
from adult animals because receptor levels change through developmental stages in mammals, 
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making age a factor that can complicate comparisons (Rothmond et al., 2012) (Sobrian et al., 
2003). 
 
1.3 DA systems 
While the functional processes for DA receptors are molecularly conserved across species, there 
are greater differences in the characteristics of neuronal populations that express and/or signal to 
DA receptors. Immunohistochemical labeling, chemical lesioning, and receptor-specific 
pharmacological testing have confirmed the presence of three general DA systems in vertebrates 
consisting of the mesolimbic system, the nigrastriatal system, and the tuberoinfundibular system 
(Nicholls, 2001). However, the tuberoinfundibular system will not be reviewed here, as it is 
primarily involved with modulating prolactin secretion from the pituitary gland (Lyons et al., 
2012). As previously stated, DA signals originate in the midbrain, and communicate to 
populations in the basal ganglia and cortical regions. The VTA in the midbrain is the synthesis 
region for DA in the mesolimbic system. DA neurons project from VTA to forebrain regions and 
the NAc, i.e. ventral striatum, (Nicholls, 2001). The mesolimbic system is characterized by high 
levels of D1 receptors in the NAc, and is involved in processes for motivation, reward- and goal-
oriented behaviors (Self, 2010). DA is also synthesized in the substantia nigra pars compacta in 
the midbrain, which projects to the dorsal striatum (caudate nucleus and putamen) to form the 
nigrostriatal system (Nicholls, 2001). The dorsal striatum expresses both types of DA receptors 
(Gurevich, 2010), and functions in motor behavior. 
 
In amniotes, coordinated motor output is controlled through functional D1 and D2 receptor 
distributions on GABAergic neurons of the dorsal striatum to produce a disinhibitory effect on 
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the basal ganglia output pathways to the thalamus and brainstem (Purves, 2001). In particular, 
two output pathways originate in the dorsal striatum, and are dependent on modulation by DA 
signaling to function properly for motor production. The striatonigral pathway, also known as the 
direct pathway, is characterized by D1 receptors and substance P, and projects to the substantia 
nigra pars reticula and external globus pallidus, while the striatopallidal pathway, also known as 
the indirect pathway, is characterized by D2 receptors, A2A receptors, and enkephalin, and 
projects to the internal globus pallidus. The internal globus pallidus also projects to the 
substantia nigra pars reticula and external globus pallidus, as well as the subthalamic nucleus 
(Deng et al., 2006) (Durieux et al., 2012) (Groenewegen, 2003). A balance between D1 receptor 
activation and D2 receptor inhibition on the GABAergic neurons in the basal ganglia is 
necessary for successful motor production. Interneurons also comprise three other neuronal 
populations in the striatum of amniotes, and function to modulate signaling in the basal ganglia 
with GABA or acetylcholine (Reiner et al., 1998). 
 
Evidence supporting neuronal population specificity comes from experiments focused on DA 
receptors in different basal ganglia nuclei. In a classic study using in situ hybridization, Gerfen et 
al. showed that striatonigral neurons express D1 receptors, dynorphin, and substance P, while the 
striatopallidal neurons express D2 receptors and enkephalin (Gerfen et al., 1990). Robertson et 
al. demonstrated treatment with the D2 receptor antagonist, haloperidol, increased Fos-ir in 
striatopallidal and enkephalin-ir neurons, although the D1 receptor partial agonist, SKF-38393, 
did not affect Fos-ir in either striatopallidal or striatonigral neurons (Robertson et al., 1992). 
Finally, Matamales et al., using nuclear staining in bacterial artificial chromosome (BAC) 
transgenic mice, showed that all striatal medium-sized spiny neurons expressed either D1 
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receptors, D2 receptors, or both, and that striatonigral neurons are specific for expressing D1 
receptors (Matamales et al., 2009). Together these results suggest functional specificity for the 
type of DA receptor that is expressed by neurons in the basal ganglia. 
  
Identification of the DA systems is possible in non-mammalian species, and has been done to 
some extent. In general, the DA systems are conserved across vertebrates, although immuno-
histochemical staining shows organizational differences and an increase in circuit complexity 
when progressing from invertebrates to amniotes (Marin et al., 1998a) (Reiner et al., 1998) 
(Smeets, 1995). Efferent neurons and axonal fibers from the striatum that correspond to the 
mammalian basal ganglia output pathways can be distinguished by protein expression patterns in 
anuran tissue (Endepols et al., 2004b) (Marin et al., 1997b). For example, retrograde labeling in 
the NAc reveals a mesolimbic-like pathway from the midbrain tegmentum in Perez’s frog (Rana 
perezi) (Marin et al., 1995). Substance P-ir fibers are located in the NAc and ventral pallidum, 
while enkephalin-ir fibers are located in the NAc and dorsal pallidum in anurans (Marin et al., 
1998b). Also immunohistochemical labeling for proteins associated with the striatal pathways in 
anuran tissue supports the presence of both direct and indirect pathways projecting from the 
dorsal striatal region (Endepols et al., 2004b). However, acetylcholinergic interneurons are much 
more sparse in anuran neural tissue (Marin et al., 1997c), as is the labeling for neuropeptides 
characteristic to the other interneuron populations, such as somatostatin, neuropeptide Y, and 
GABA (Endepols et al., 2007) (Reiner et al., 1998). Overall, data support the presence of 
projection pathways to and from the striatum in anuran neural tissue similar to those in other 
vertebrates, however the cell density of specific neuronal populations in the basal ganglia is 
much lower in anurans compared to the patterns seen in other amniotes. 
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1.4 Roles of DA in behavior 
The modulatory role of DA on neuronal signaling can be seen directly in behavior and motor 
output, however it also acts in cognitive processes (Mink, 1996) (Gerfen, 1996). In mammalian 
research, a large amount of attention is directed to DA processes in the telencephalon and its 
influence on cognitive processes for attention, memory, and emotion, as well as sensory-motor 
integration. However, the fact that DA receptor-specific treatments result in similar behavioral 
effects across different species that lack cortical signaling supports the conservation of DA in 
behavioral processes at neural levels less complex than the cortex. Human diseases, such as 
schizophrenia and Parkinson’s disease, have distinct behavioral symptoms that are due to 
different impairments in the central DA systems (Mink, 1996) (Groenewegen, 2003) (Muller et 
al., 2003). Animal models representing these neurobiological impairments and comparable 
behavioral effects demonstrate how well the DA systems are conserved in motor processing and 
initiation of action signaling. By testing the effects of manipulation of the DA system on motor 
behaviors in anurans, we can bypass the influence of cortical input on basal ganglia processes for 
motor behavior, and focus on receptor signaling in the thalamus and brainstem for behavior. 
 
As previously stated, in mammalian basal ganglia, DA stimulates motor signals through D1 
receptors in the direct striatonigral pathway, and inhibits motor signals through D2 receptors in 
the indirect striatopallidal pathway (Gerfen, 1996) (Morelli et al., 2007). Examples that support 
DA signaling in motor behaviors are present in the DA receptor-specific data from studies on 
locomotor behaviors in mammals. To start, ablation of D2 receptors in dorsal striatal tissue 
results in hyperlocomotion, while ablation of D1 receptors results in reduced locomotion 
(Durieux et al., 2012). The opposite effects occur when specific receptors are stimulated in the 
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dorsal striatum. In particular, D1 receptor-specific optogenetic stimulation increases locomotion, 
while D2 receptor-specific stimulation decreases locomotion (Kravitz et al., 2010). QUIN, the 
D2 receptor-specific agonist, reduces motor behaviors when administered at low doses by 
resulting in a decrease in DA release (Starke et al., 1989), although this effect of QUIN on motor 
behavior is not seen in D2 receptor total genetic knock-out mice (Usiello et al., 2000).   
 
The behavioral effects of DA manipulation in anurans are consistent with the patterns found in 
mammal data. Lesions to DA-specific neurons with 6-OHDA in gray tree frogs (Hyla versicolor) 
result in severe motor impairments that correlate with the extent of damage (Endepols et al., 
2004a). Also Ewert et al. have shown DA involvement in prey-catching behaviors in the 
common toad (Bufo bufo). In particular, treatment with the non-specific DA agonist, 
apomorphine (APO), alters a toad’s “hunting strategy” to a “waiting strategy” by facilitating 
snapping behavior toward a target when within reach, although not tracking a target when 
moving out of the reaching field (reviewed in Ewert et al., 2001). APO also increases the time 
spent climbing in a motor task on northern leopard frogs (Lithobates pipiens, formerly known as 
Rana pipiens) (Chu and Wilczynski, 2007). Immediate-early gene activation in the midbrain 
tegmentum is more strongly correlated with locomotor behavior than with a social signal 
stimulus in female túngara frogs (Engystomops pustulosus, formerly known as Physalaemus 
pustulosus) when exhibiting a phonotaxic response to species-specific auditory stimuli (Hoke et 
al., 2007). Recent field data on H. cinerea showed IP treatment with QUIN inhibited calling 
behavior, while treatment with either a D1 receptor partial agonist, SKF-38393, or APO did not 
affect call rates (Creighton et al., 2013). However, no motor tests were conducted in the field, 
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and it is possible the inhibition of calling behavior could be due to a motor impairment following 
QUIN treatment.  
 
1.5 Experimental focus 
The goal of the following experiments is to contribute to the answer for the general question- Are 
the behavioral processes of the DA systems conserved across vertebrates? These experiments 
focus on manipulation of D2 receptors in H. cinerea for motor processes involved in a task that 
requires swimming, climbing, and crawling actions (Chu and Wilczynski, 2007) (Chu, 2008), 
with the hypothesis that DA modulates motor behaviors in H. cinerea as in mammals, and the D2 
receptor has an inhibitory role in motor output. Because DA receptor distribution in the neural 
pathway for call output is unknown in anurans, we cannot determine the extent of the effect of 
QUIN treatment on call behavior that is due to motor inhibition based on D2 receptor signaling 
in a motor pathway, or due to an impaired ability to initiate calling based on D2 receptor 
signaling in the mesolimbic pathway. By examining the effects of D2 receptor-specific agonist 
QUIN, and antagonist, haloperidol (HAL), on motor behaviors, the following experiments aim to 
reveal the role of D2 receptors in different motor behaviors and incentive responses in H. 
cinerea. HAL is a typical neuroleptic prescribed to treat mental illness that acts mainly by 
blocking D2 receptors, among others. At a molecular level, HAL promotes c-Fos expression 
(Robertson et al., 1992) and phosphorylation of ERK pathways in striatopallidal neurons that 
express D2 receptors (Bertran-Gonzalez et al., 2008), while QUIN prevents phosphorylation of 
tyrosine hydroxylase in the DA synthesis pathway (Lindgren et al., 2001), and decreases 
DARPP-32 phosphorylation in dorsal striatal projection pathways (Lindskog et al., 1999). Based 
on the functional processes of the D2 receptor in mammalian basal ganglia and motor behaviors, 
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it is predicted that a D2 receptor agonist will decrease motor behavior (hypoactivity), while a D2 
receptor antagonist will increase motor behavior (hyperactivity) in H. cinerea if the anuran basal 
ganglia relies on DA receptors for modulation of signal output, as in amniotes. Also evidence 
points to DA involvement in behavioral conditioning and learning in vertebrates (Smith et al., 
2006) (Wise, 2004). Thus, if D2 receptors act similarly across vertebrates in the behavioral 
conditioning process, then behavior performance should improve following D2 agonist treatment 
in H. cinerea, however this may not be the case with D2 antagonist treatment. It is also possible 
that a balance between D1 and D2 receptor activation may be necessary for successful 
conditioning, as with motor output, and if this is the case, then either agonist or antagonist 
treatment will interfere with learning the motor procedure. Overall, these data will contribute to 
our understanding of how DA processes work to modulate behavior by demonstrating the 
behavioral effects of receptor-specific drugs in a more simplistic model of vertebrate DA 
systems in H. cinerea.  
 
2  METHODS AND RESULTS 
2.1 General procedures 
2.1.1 Subjects 
Adult green tree frogs, H. cinerea, were used in Experiments 1 and 2. Frogs were separated by 
sex, and housed in groups of 4-7 in glass aquaria. Each aquarium contained a shelter unit, water 
dish, and a small artificial plant for environmental enrichment. Water was provided ad libitum, 
and crickets (1cm) were provided twice per week as food. Feeding days were spaced so as to 
allow at least 1 day to pass after being fed before behavioral testing in order to avoid motor 
interference from any digestive processes. 
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2.1.2 Behavioral testing 
All experiments implemented a motor test that requires swimming and climbing behaviors. The 
testing apparatus consisted of a swimming pool (122cm diameter) lined with red clay bricks 
(brick size: 45.6cmx9cmx5.5cm), and filled ~10-18cm deep with tap water (Figs 1a and 1b). 
Pool water was replaced every 3-4 days. A stationary camera was connected to a computer (Dell 
Opti-PLEX GX60), and directed to the pool. Digital recordings were made of each experimental 
trial for all subjects with Microsoft Windows Media Encoder 9 (version #9.00.00.2980). 
 
In general, 3-5 subjects were tested per day. Each frog underwent 14 experimental trials on 4 
different days that consisted of an acclimation period and a test session. The acclimation period 
allowed the frog to adjust to the aquatic environment prior to treatment, and trial procedures 
were the same for the test session trials following treatment as trials in the acclimation period. 
Each trial began by releasing the frog closely above the water in the center of the pool, and 
allowing the frog to swim to and climb the bricks lining the inside of the pool. Trial timing 
started when the frog entered the water and continued to total 3 minutes. Following the fourth 
acclimation trial, the frog received an intraperitoneal (IP) injection of either a control or a test 
treatment, and was placed in a dark aquarium for 20 minutes (post-injection period). Control 
treatment was administered on the first and last day of testing, and each frog received a different 
test treatment on an intermediate day of test sessions. The order of treatment administration was 
balanced by dose and by sex. After the post-injection period, the test session was initiated, and 
the frog underwent 10 trials procedurally identical to the acclimation trials. After termination of 
the 10th trial in the test session, the frog was returned to its home tank. No test sessions extended 
 13 
 
longer than 35 minutes, and at least 96 hours (4 days) passed before the next experimental trial 
for the same frog. Details for test sessions in Experiment 1 and Experiment 2 are presented 
below. 
 
2.1.3 Statistical analysis 
Time measures for behaviors were collected from 2 viewings of the digital recordings of the 10 
post-injection test session trials using Media Player Classic (version #1.6.4.6052), and the time 
measures from each viewing were averaged for statistical analyses (inter-rater reliability 
Experiment 1 Pearson’s r=0.68, Experiment 2 Pearson’s r=0.99). The viewer was blind to 
treatment during the behavioral analysis. Table 1 lists the behaviors that were measured in 
Experiments 1 and 2. Measures are based on the average of all 3-minute trials per test session. 
Trial time is a measure of the time between entrance into the water of the testing arena and either 
when the frog exited the arena or when the trial ended at 3 minutes (180s), whichever came first. 
Total time spent swimming is a measure of the amount of time the frog exhibited swimming 
movements and motion in water. Total time in water is a measure of the amount of time the frog 
was in water in the arena. Total time spent climbing is a measure of the amount of time the frog 
was in a vertical position, attached to and/or moving vertically on either the bricks or the pool 
wall. Vertical settle refers to the total time the frog was immobile in a vertical position attached 
to the brick or pool wall. Vertical settle in water is a measure of the amount of time the frog was 
immobile in a vertical position attached to brick in water. Total time spent in a horizontal 
position is a measure of the amount of time the frog was immobile in a horizontal position on the 
bricks, or in Experiment 1, also on the top edge of the pool wall. Total time in air is a measure of 
the amount of time the frog was not in contact with a surface because of a jump or hop motion.  
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Due to small group sizes and balancing for sex and treatment order effects, the independent 
variable used in analysis for drug effect in either experiment was Treatment (k=3), with the 
average of the Pre-treatment and Post-treatment control measures as the control variable. 
Outliers (defined as measures at least 2 standard deviations from the mean) were removed before 
statistical calculations began. Treatment effects were analyzed with either a parametric one-way 
repeated measure (RM) ANOVA or a non-parametric Friedman RM ANOVA on ranks, 
depending on data distribution. In some cases of non-parametric distributions, data 
transformation by natural log normalized the distribution, and a parametric RM ANOVA was 
conducted. However if the distribution remained non-normalized after natural log 
transformation, the original measures were used in a non-parametric Friedman RM ANOVA on 
ranks. Post-hoc tests consisted of Tukey’s HSD test (for parametric data) or Friedman post-hoc 
equation (for non-parametric data) (Experiment 1 Friedman critical difference CDF=9.94; 
Experiment 2 Friedman critical difference CDF=10.81) (Sheskin, 2007). Conditioning effects, 
defined as performance improvement based on trial repetition, were tested by a paired t-test or 
Wilcoxon signed rank test on measures from the control treatment days across all subjects in 
either experiment (Experiment 1 N=12; Experiment 2 N=25). Significance was confirmed at 
P<0.05. Statistics were calculated using SigmaStat 3.5, and data were plotted using SigmaPlot 
10.0. Measures are reported as mean±standard deviation in the text. 
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      Fig 1.1 Testing arena for Experiment 1         Fig 1.2 Testing arena for Experiment 2 
 
Testing arenas were arranged differently for Experiments 1 and 2. In Experiment 1, a color-sensitive camera was assembled to record the pool at 
an angle, and bricks were arranged horizontally. In order to prevent subjects from traveling in poorly visible areas, bricks were not stacked to 
reach above water level on one third of the pool siding (Fig 1.1). In Experiment 2, bricks were arranged vertically to line the pool, thus limiting the 
amount of hiding space. A black-and-white camera was assembled over the pool, and a red-tinted light was attached near the camera to create 
enough light for clear recording (Fig 1.2). The brick and camera arrangement allowed for fewer hiding areas and better tracking of behaviors 
during the trials in Experiment 2, resulting in stronger inter-rater reliability. 
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Table 1. Treatment Tests and Effects Summary. Different behaviors were analyzed from the digital recordings of each subject following 
treatment, and the statistical results are summarized below. For parametric distributions, drug effects were tested by a one-way ANOVA with a 
post-hoc Tukey’s HSD test, if significant, and conditioning effects were tested by a paired t-test. For non-parametric distributions, drug effects 
were tested by a Friedman’s one-way ANOVA with a Friedman post-hoc test (QUIN CDF=9.94; HAL CDF=10.81), if significant, and conditioning 
effects were tested by a Wilcoxon signed rank on measures test. QUIN abbreviations: C, control, L, low dose 0.1mg/kgbw, H, high dose, 
1.0mg/kgbw; HAL abbreviations: C, control, L, low dose 0.12mg/kgbw, H, high dose, 1.2mg/kgbw 
 
Treatment tests and effects summary 
 QUIN HAL 
Dependent 
variable (sec) 
Drug effect 
N=12 Post Hoc 
Conditioning effect 
N=12 
Drug effect 
N=14 Post Hoc 
Conditioning effect 
N=25 
Trial time 
No: 
F(2, 11)=1.11, 
P=0.35 
- 
Yes: 
t(10)=3.54, 
P<0.05 
No: 
F(2, 13)=0.79, 
P=0.47 
- 
Yes: 
t(22)=4.42, 
P<0.05 
Total time spent 
swimming 
No: 
χ2=4.22, P=0.15 
 
- 
 
No: 
t(10)=1.72, 
P=0.12 
No: 
χ2=1.08, P=0.58 - 
No: 
z=-0.77, P=0.59 
Total time in 
water 
Yes: 
F(2, 11)=5.36, 
P<0.05 
Tukey L vs H: 
q=4.31, P=0.02 
Yes: 
z=-2.55, P<0.05 
Yes: 
χ2=12.67, P<0.05 
CDF<CD|C-L| 
CDF<CD|C-H| 
Yes: 
t(20)=2.06, 
P=0.05 
Total time spent 
climbing 
No: 
F(2, 11)=3.42, 
P=0.053 
- 
Yes: 
t(10)=3.68, 
P<0.05 
No: 
F(2, 13)=0.43, 
P=0.66 
- 
No: 
t(23)=1.76, 
P=0.09 
Time spent in 
vertical settle 
position in water 
- 
 
- 
 
- Yes: 
χ2=10.80, P<0.05 
CDF<CD|C-L| 
CDF<CD|C-H| 
Yes: 
z=-1.99, P<0.05 
Total time spent 
in vertical settle 
position 
Yes: 
F(2, 11)=4.92, 
P<0.05 
Tukey L vs H: 
q=4.30, P=0.02 
Yes: 
t(9)=3.67, P<0.05 
No: 
χ2=1.86, P=0.40 - 
No: 
t(23)=0.49, 
P=0.63 
Total time spent 
in horizontal 
position on brick 
No: 
F(2, 11)=0.32, 
P=0.73 
- 
Yes: 
t(10)=2.45, 
P<0.05 
No: 
χ2=3.00, P=0.22 - 
No: 
t(22)=1.87, 
P=0.08 
Total time in air 
Yes: 
F(2, 11)=11.80, 
P<0.05 
Tukey H vs L: 
q=5.92, P=0.001 
Tukey H vs C: 
q=5.71, P=0.002 
No: 
t(10)=-1.24, 
P=0.24 
Yes: 
F(2, 13)=3.87, 
P<0.05 
Tukey C vs L: 
q=3.75, P=0.04 
Yes: 
t(23)=-2.26, 
P<0.05 
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2.2  Experiment 1 Details 
2.2.1 Subjects 
H. cinerea were collected (with permit) from the Charlie Elliott Wildlife Reservation (Mansfield, 
GA), and housed on Agnes Scott College campus (Decatur, GA) during the summer of 2010 in a 
greenhouse receiving natural light and temperature. Housing and testing procedures were 
reviewed and approved by the Agnes Scott College IACUC before initiation of the Experiment 
1. A total of 12 frogs (5 females: 7 males) were used in Experiment 1. The average body weight 
of frogs taken prior to the first day of testing was 7.5±1.9g.  
 
2.2.2 Treatments 
Quinpirole hydrochloride (QUIN) was purchased in powder form from Sigma-Aldrich (product 
#Q102), and dissolved in amphibian Ringer’s solution. It was administered in 140µl as a low 
dose (0.75µg, i.e. 0.1mg/kgbw) or a high dose (7.5µg, i.e. 1.0mg/kgbw) based on previous field 
data testing the effects of QUIN on calling behavior (Creighton et al., 2013). Control treatment 
consisted of 140µl of amphibian Ringer’s solution. Treatments were delivered by IP injection 
following the acclimation period in behavioral testing. All frogs received either the high or low 
QUIN treatment on different days (see Table 2). 
 
2.2.3 Details for Experiment 1 testing procedure 
Testing started at 1900 each evening, and lasted until 0200. Experiment 1 utilized a color 
stationary color camera (Panasonic CCD model #KP-C550U-S2) for visual recording. Data from 
test days are referred to as control, low QUIN, and high QUIN, based on treatment. 
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Table 2. Experiment 1. QUIN Swim-Climb Test Subjects. Twelve frogs were used in Experiment 1, and received a low dose (0.1mg/kgbw) 
or high dose (1.0mg/kgbw) of QUIN, a D2 receptor agonist, on different intermediate test days. QUIN treatments were balanced by order and sex, 
while control treatment was administered on the first and last days of testing. At least 4 days passed between each behavioral test day for a subject. 
 
Experiment 1. QUIN Swim-Climb Test Subjects 
 Subject Sex Day 1 Day 2 Day 3 Day 4 
 
1 
 
1A 
 
M Pre-treatment Control 
 
Low QUIN 
 
High QUIN Post-treatment Control 
 
2 
 
2A 
 
M Pre-treatment Control 
 
High QUIN 
 
Low QUIN Post-treatment Control 
 
3 
 
2D 
 
M Pre-treatment Control 
 
Low QUIN 
 
High QUIN Post-treatment Control 
 
4 
 
3A 
 
F Pre-treatment Control 
 
Low QUIN 
 
High QUIN Post-treatment Control 
 
5 
 
4B 
 
F Pre-treatment Control 
 
Low QUIN 
 
High QUIN Post-treatment Control 
 
6 
 
4E 
 
F Pre-treatment Control 
 
Low QUIN 
 
High QUIN Post-treatment Control 
 
7 
 
4F 
 
F Pre-treatment Control 
 
High QUIN 
 
Low QUIN Post-treatment Control 
 
8 
 
4G 
 
F Pre-treatment Control 
 
High QUIN 
 
Low QUIN Post-treatment Control 
 
9 
 
5C 
 
M Pre-treatment Control 
 
High QUIN 
 
Low QUIN Post-treatment Control 
 
10 
 
5D 
 
M Pre-treatment Control 
 
High QUIN 
 
Low QUIN Post-treatment Control 
 
11 
 
5E 
 
M Pre-treatment Control 
 
Low QUIN 
 
High QUIN Post-treatment Control 
 
12 
 
5G 
 
M Pre-treatment Control 
 
High QUIN 
 
Low QUIN Post-treatment Control 
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2.3  Experiment 1 Results 
2.3.1 Treatment effects 
While no significant differences were present in the swimming measures across QUIN 
treatments (Friedman χ2=4.22, P=0.15) (Fig 2a), there was a treatment effect on the total amount 
of time a frog spent in water per trial (F(2, 11)=5.36, P<0.05, adjusted to natural log) (Fig 2b). 
Frogs spent significantly more time in water following high QUIN treatment (30.93s±26.10s) 
compared to low QUIN treatment (7.75±6.05s) (Tukey’s q=4.31, P=0.02), and although similar 
to low QUIN results, there was no effect of control treatment (9.48±5.23s). Overall, frogs 
remained in the water for a longer amount of time following the high QUIN dose. 
 
 The total time spent climbing (i.e. in a vertical position) was greatest following high QUIN 
treatment, although not significant (F(2,11)=3.42, P=0.053) (Fig 2c). In particular, time spent in a 
vertical settle position was significantly increased with high QUIN treatment (55.62±37.67s) 
compared to low QUIN treatment (19.55±20.44s) (F(2, 11)=4.92, P<0.05; Tukey’s q=4.30, 
P=0.02) (Fig 2d). However, it is noted there were no significant treatment effects on the time to 
reach the top of the bricks (Friedman χ2=3.46, P=0.18) (data not shown), and there were no 
significant differences in the amount of time spent in a horizontal position (i.e. sitting) following 
any QUIN treatments (F(2, 11)=0.79, P=0.47) (Fig 2e). These results suggest that while frogs 
showed no influence of QUIN on the ability to reach the bricks by swimming, the high QUIN 
treatment resulted in a preference to remain in a vertical position, even upon reaching the top of 
the bricks. 
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Fig 2. Behavioral changes following QUIN treatments. While QUIN treatment did not affect the 
amount of time frogs exhibited the swimming motions (a), the high QUIN dose (1.0mg/kgbw) 
significantly increased the total amount of time the frogs remained in the water per trial on average (b). A 
trend appeared for general climbing movements (F(2, 11)=3.42, P=0.053) (c), and frogs spent significantly 
more time in the vertical settle position when treated with the high QUIN dose compared to the low 
QUIN dose (d). No significant effects on the amount of time spent in a horizontal settle position were 
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found (e), although the amount of time for air travel decreased significantly following high QUIN 
treatment compared to low QUIN and control treatments (f). Vertical bar values represent the mean±SD. 
P-values represent the post-hoc results.  
 
A measure of travel used in this analysis was the size of a frog’s jumps, determined by the 
amount of time the frog spent in the air (air travel). This was chosen based on the jumping 
movement of the frog being a readily identified action. QUIN treatment decreased the time in air 
(F(2, 11)=11.80, P<0.05) (Fig 2f). In particular, high QUIN treatment (0.08±0.05s) resulted in 
significantly less time in air than low QUIN treatment (0.20±0.12s) (Tukey’s q=5.92, P<0.01) 
and control treatment (0.19±0.06s) (Tukey’s q=5.71, P<0.01). Overall, the amount of time the 
frogs were not in contact with a surface was similar between the low QUIN and control 
treatments, and both were greater than the high QUIN treatment, suggesting extended immobility 
on a solid surface after high QUIN treatment, since jumping and hopping are the typical forms of 
travel for these frogs. 
 
2.3.2 Conditioning effects 
Improvement in behavioral task performance is often seen after repeated trials (conditioning 
effect) in other organisms, including other anurans (Muzio et al., 1992), and the question was 
asked whether H. cinerea would show improvement even under drug manipulation on D2 
receptors. Conditioning effects were measured in Experiment 1 as significant differences in 
behavioral measures from the days of control treatment, which were given on the first day (Pre-
treatment control) and last day (Post-treatment control) of testing. Trial time measures decreased 
significantly from Pre-treatment control (158.62±16.71s) to Post-treatment control 
(136.37±15.49s) (t(10)=3.54, P<0.05) (Fig 3a). This means frogs exited the arena faster on the last 
day of testing compared to the first day. The total amount of time in water decreased 
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significantly between Pre-treatment control (14.51±11.67s) and Post-treatment control 
(2.18±0.72s) (Wilcoxon signed rank, Z=-2.55, P<0.05) (Fig 3b). The total amount of time spent  
climbing decreased between Pre-treatment control (52.37±35.01s) and Post-treatment control  
(9.09±8.33s) (t(10)=3.68, P<0.05) (Fig 3c), particularly time spent in the vertical settle position 
(t(9)=3.67, P<0.05) (Fig 3d). Also the amount of time frogs spent immobile in the horizontal 
settle position decreased significantly between Pre-treatment control (57.13±23.53s) and Post-
treatment control (46.34±24.46s) (t(10)=2.45, P<0.05) (Fig 3e). Measures for time of air travel 
increased between Pre-treatment control and Post-treatment control, although not significantly 
(t(10)=-1.24, P=0.24) (Fig 3f). Overall the conditioning effects point toward increased movement 
and improved behaviors generally directed toward exiting the arena, thus resulting in decreased 
trial times for all subjects on Post-treatment control day compared to Pre-treatment control day.  
 
  
Fig 3.1 Conditioning effects of repeated trials with QUIN treatment. QUIN treatment resulted 
in improved performance in some tasks, measured as a decrease in time from Pre-treatment measures 
(Pre) and Post-treatment measures (Post). In general, frogs showed a decrease in the amount of time to 
exit the arena in the Post-treatment control measures compared to the Pre-treatment control measures (a). 
In line with decreased trial time are fewer displays of other behaviors while in the arena on the final day 
of testing, including time in water (b). Vertical bar values represent the mean±SD.  P-values represent 
significant differences in the paired t-test or Wilcoxon signed rank test. 
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Fig 3.2 Conditioning effects of repeated trials with QUIN treatment. QUIN treatment resulted 
in improved performance in some tasks, measured as a decrease in time from Pre-treatment measures 
(Pre) and Post-treatment measures (Post). Other behaviors that decreased between Pre-treatment control 
measures and Post-treatment control measures include climbing movement (c), vertical settle position (d) 
and horizontal settle position (e). While air travel increased in Post-treatment measures (f), it was not 
significant. Vertical bar values represent the mean±SD.  P-values represent significant differences in the 
paired t-test or Wilcoxon signed rank test. 
 
2.4  Experiment 2 Details 
2.4.1 Subjects 
H. cinerea were purchased from Charles D. Sullivan Co. Inc., and housed in aquaria on a reverse 
long-day light cycle (14L:10D) in a room designated for amphibian housing at Georgia State 
University Neuroscience Institute in late summer of 2011. Temperature was maintained between 
20-25°C. All housing and testing procedures were approved by Georgia State University IACUC 
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before testing was initiated for Experiment 2. A total of 25 frogs (15 females: 10 males) were 
used in Experiment 2. Feeding was decreased to once per week after an observation that the body 
weights of frogs were increasing considerably before testing began. The average body weight of 
frogs in Experiment 2 taken prior to the first day of testing was 8.4±1.4g. 
  
2.4.2 Treatments 
Haloperidol (HAL; 50mg) was purchased in stock solution with lactic acid from SAGENT 
Pharmaceuticals (Schaumburg, IL). Treatment doses (based on 8.4gbw) were prepared using a 
working stock solution in amphibian Ringer’s solution. A low dose (1µg, i.e. 0.12mg/kgbw) or a 
high dose (10µg, i.e. 1.2mg/kgbw) of HAL was diluted from the working stock and administered 
in 100µl IP injections. A vehicle group (LA; n=5) received a 100µl IP injection of a 2% lactic 
acid solution on experimental treatment days. To serve as a conditioning control in Experiment 
2, a group of frogs (ARS; n=6) received only control treatment of amphibian Ringer’s solution 
on all behavioral test days (see Tables 2.1 and 2.2 for all groups). Doses were based on 
mammalian behavioral data (Huang et al., 2010) (Salamone et al., 1996). 
 
2.4.3 Details for Testing apparatus and procedure for Experiment 2 
The same testing apparatus as used in Experiment 1 was constructed in the housing room for 
Experiment 2, however there were some differences in the arrangement of bricks and lighting 
(Fig 1b). Bricks were arranged vertically to line the swimming pool siding. This allowed better 
visibility of the frog in the pool, and it resulted in less enclosed vertical surface area. White, 
plastic-covered cardboard surrounded the pool to prevent test subjects from escaping recapture in  
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Table 3.1 HAL Swim-Climb Test Subjects. Treatment Group 1. A total of 25 subjects were used in Experiment 2. Treatment group 1 
consisted of 14 subjects that were administered either a low dose (0.12mg/kgbw) or high dose (1.2mg/kgbw) of HAL, a D2 receptor-specific 
antagonist. Treatment was balanced by order and sex on intermediate test days, while control treatment was administered on the first and last days 
of testing. 
 
 
 
 
 
 
 
 
 
 
  
Experiment 2. HAL Swim-Climb Test Subjects 
Treatment Group 1 
 Subject Sex Day 1 Day 2 Day 3 Day 4 
 
1 
 
S23 
 
F 
Pre-treatment 
control 
 
High HAL 
 
Low HAL 
Post-treatment 
Control 
 
2 
 
S24 
 
F 
Pre-treatment 
control 
 
Low HAL 
 
High HAL 
Post-treatment 
control 
 
3 
 
T17 
 
M 
Pre-treatment 
control 
 
High HAL 
 
Low HAL 
Post-treatment 
control 
 
4 
 
T18 
 
M 
Pre-treatment 
control 
 
Low HAL 
 
High HAL 
Post-treatment 
control 
 
5 
 
U30 
 
F 
Pre-treatment 
control 
 
High HAL 
 
Low HAL 
Post-treatment 
control 
 
6 
 
U31 
 
F 
Pre-treatment 
control 
 
Low HAL 
 
High HAL 
Post-treatment 
control 
 
7 
 
W13 
 
M 
Pre-treatment 
control 
 
High HAL 
 
Low HAL 
Post-treatment 
control 
 
8 
 
W16 
 
M 
Pre-treatment 
control 
 
Low HAL 
 
High HAL 
Post-treatment 
control 
 
9 
 
X11 
 
M 
Pre-treatment 
control 
 
High HAL 
 
Low HAL 
Post-treatment 
control 
 
10 
 
X12 
 
M 
Pre-treatment 
control 
 
Low HAL 
 
High HAL 
Post-treatment 
Control 
 
11 
 
Y5 
 
F 
Pre-treatment 
control 
 
Low HAL 
 
High HAL 
Post-treatment 
Control 
 
12 
 
Y6 
 
F 
Pre-treatment 
control 
 
High HAL 
 
Low HAL 
Post-treatment 
Control 
 
13 
 
Z2 
 
F 
Pre-treatment 
control 
 
High HAL 
 
Low HAL 
Post-treatment 
Control 
 
14 
 
Z4 
 
F 
Pre-treatment 
control 
 
Low HAL 
 
High HAL 
Post-treatment 
Control 
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Table 3.2 HAL Swim-Climb Test Subjects. Treatment Groups 2 and 3. Treatment group 2 served as a vehicle control group, and 
subjects were treated with a 2% lactic acid solution (LA) on intermediate test days. Treatment group 3 served as a conditioning test group, and 
subjects received the control amphibian Ringer’s solution (ARS) on all test days. All subjects went through a motor test measuring the treatment 
effects on swimming and climbing behaviors, and at least 4 days passed between each test day in Experiment 2. 
 
Experiment 2. HAL Swim-Climb Test Subjects 
Treatment Group 2 
 Subject Sex Day 1 Day 2 Day 3 Day 4 
 
1 
 
S21 
 
M 
Pre-treatment 
control 
 
LA 
 
LA 
Post-treatment 
control 
 
2 
 
U29 
 
F 
Pre-treatment 
control 
 
LA 
 
LA 
Post-treatment 
control 
 
3 
 
V28 
 
F 
Pre-treatment 
control 
 
LA 
 
LA 
Post-treatment 
control 
 
4 
 
X10 
 
M 
Pre-treatment 
control 
 
LA 
 
LA 
Post-treatment 
control 
 
5 
 
Y8 
 
F 
Pre-treatment 
control 
 
LA 
 
LA 
Post-treatment 
control 
Treatment Group 3 
  Subject Sex Day 1 Day 2 Day 3 Day 4 
 
1 
 
S22 
 
F 
Pre-treatment 
control 
 
ARS 
 
ARS 
Post-treatment 
control 
 
2 
 
T19 
 
M 
Pre-treatment 
control 
 
ARS 
 
ARS 
Post-treatment 
control 
 
3 
 
V27 
 
F 
Pre-treatment 
control 
 
ARS 
 
ARS 
Post-treatment 
control 
 
4 
 
X9 
 
M 
Pre-treatment 
control 
 
ARS 
 
ARS 
Post-treatment 
control 
 
5 
 
Y7 
 
F 
Pre-treatment 
control 
 
ARS 
 
ARS 
Post-treatment 
control 
 
6 
 
Z1 
 
F 
Pre-treatment 
control 
 
ARS 
 
ARS 
Post-treatment 
control 
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the room after exiting the arena. A stationary black-and-white camera (Panasonic CCTV model 
WV-BP330) was connected to a computer (Dell Opti-PLEX GX60), assembled on a pole over 
the pool, and directed toward the water. Anuran eyes lack receptors to red light (Stebbins, 1997), 
thus in order to generate enough light to record the behavioral tests without disrupting the 
reverse light-dark cycle of the room, a red light was fixed near the camera for filming. 
Experiment sessions followed the same behavior protocol as Experiment 1. Lights went off at 
0700; experiment sessions started between 0800-1000, and lasted until 1500-1800. 
 
2.5  Experiment 2 Results 
2.5.1 Treatment Effects 
Analysis 2a  
There were no significant changes in swimming behaviors following any HAL treatments (Fig 
4a). However, the total amount of time spent in water decreased significantly with each HAL 
dose compared to control treatment (Friedman χ2=12.67, P<0.05; CD|C-L|=15, CD|C-H|=18) (Fig 
4b).  This means that while the frogs did not differ in the amount of time to reach the brick 
siding, they exited the water faster and remained on a dry surface longer when treated with either 
HAL dose than when treated with control. 
 
Neither HAL treatment had any effects on the total amount of time spent climbing (F(2, 13)=0.43, 
P>0.05) (Fig 4c). However, HAL treatments did result in changes to time spent in the vertical 
settle position in water (Friedman χ`=10.80, P<0.05) (Fig 4d). Post-hoc testing shows both HAL 
treatments (low HAL: 6.88±10.71s, CD|C-L|=15.5; high HAL: 7.74±10.86s, CD|C-H|=15.5) 
decreased the time spent in vertical settle position in water compared to control treatment 
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(13.37±13.38s), although there were no differences in the total amount of time spent in vertical 
settle position when including time on a dry surface (Friedman χ2=1.86, P>0.05) (Fig 4e). This 
behavioral difference supports the general decrease in time spent in water following HAL 
treatment. Both HAL treatments showed similar measures for time in air (high HAL: 0.11±0.06s; 
low HAL: 0.13±0.07s) (Fig 4f), although only the low dose was significantly greater than the 
control treatment (0.08±0.05s) (F(2, 13)=3.87, P<0.05; Tukey’s q=3.75, P=0.04). However this 
effect is viewed with caution after vehicle control analysis (see Analysis 2b).  
 
Analysis 2b 
Because HAL must be dissolved in an acidic solution for administration, it is possible the acid 
may have a molecular effect that results in behavioral changes. For this reason, a second test 
group received a 2% lactic acid solution (LA) on the intermediate test days (Treatment group 2). 
The second analysis predicted if the HAL treatments were ineffective and behavioral changes 
were due to LA in the treatments, then the differences (measured by percent of change) between 
measures of the HAL-treated frogs from the LA-treated average should not be significant when 
tested in a one-way ANOVA by treatment. Analyzing the percent of change between the LA-
treated vehicle group mean and HAL-treated subjects across the significant behavioral data 
reveals evidence for an effect of LA in certain behaviors. Specifically, the percent of change 
between the vehicle group mean and treatment groups in the total amount of time in air did not 
differ significantly across treatment days (one-way RM ANOVA, F(3,13)=0.50, P=0.68). Overall, 
these data support the possibility that the changes seen in jumping behaviors following HAL 
treatment are no different than the changes due to LA treatment only. Other tests on the measures 
that had significant treatment effects (total time in water and vertical settle in water) showed 
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significant differences in percent of change from the vehicle group mean on treatment days, 
which supports the behavioral differences in the treatment group were due to HAL and not lactic 
acid in the treatment solutions. 
 
 2.5.2 Conditioning Effects 
In order to determine whether the changes in behaviors between the Pre-treatment control and 
Post-treatment control tests were due to conditioning alone or included drug effects, a test group 
(n=6) was included in Experiment 2 that received only control treatment for all test sessions. 
Data from this group were analyzed in a one-way RM ANOVA by Day (k=4). No significant 
differences were present in the behaviors of interest, although trends in the data suggest this may 
be due to the small sample size and high variability among individuals in the group. 
 
Still, significant differences were present between Pre-treatment control and Post-treatment 
control measures when analyses included all subjects (N=25). Trial time decreased between Pre-
treatment control (156.94±33.83s) and Post-treatment control (118.57±38.32s) (paired t-test, 
t(22)=4.42, P<0.05) (Fig 5a). The amount of time to first exit the water decreased significantly 
from Pre-treatment control (20.08±18.39s) to Post-treatment control (11.413±11.28s) (t(22)=2.52, 
P<0.05) (Fig 5b). However, when including any re-entry into water throughout the 3-minute 
trial, the post-treatment measures rose and lost significance, although keeping a trend for total 
time in water (t(20)=2.06, P=0.053) (Fig 5c). This means on the final day of testing, while taking 
less time to exit the water upon first entry, frogs were more likely to re-enter the water during a 
trial. Also while a trend was present for time spent climbing (t(23)=1.76, P=0.09) (Fig 5d), further 
analysis shows frogs spent significantly less time in the vertical settle position in water in Post-
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treatment control (10.15±11.16s) compared to Pre-treatment control (14.81±15.79s) (t(20)=2.15, 
P<0.05) (Fig 5e). However analysis of the total time in vertical settle position did not reveal a 
significant effect (t(23)=1.71, P=0.10) (Fig 5f). These data support improved behavior to exit 
water, but no change in preference for a vertical position across trials in general. Notably, the 
amount of time spent in air increased significantly between the Pre-treatment control 
(66.4±58.1ms) and Post-treatment control (98.6±52.2ms) (t(23)=2.26, P<0.05). Similar to the 
conditioning effects seen in Experiment 1, these results suggest behavior improvement still 
occurred in movements directed toward exiting the arena even under D2 antagonist treatment. 
 
  
Fig 4.1 Behavioral changes following HAL treatment. HAL treatments tended to decrease 
measures for behaviors associated with being in water. While neither treatment has any effect on time 
spent swimming (a), both treatments significantly decreased the total amount of time in water per trial (b). 
Friedman’s critical difference value (CDF)=10.81. Vertical bar values represent the mean±SD. P-values 
represent the post-hoc results. 
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Fig 4.2 Behavioral changes following HAL treatment. HAL treatments tended to decrease 
measures for behaviors associated with being in water. Although there were no differences in general 
climbing movements (c), both HAL treatments decreased the time frogs spent in a vertical settle position 
in water (d). However no differences were present in the total time spent in vertical settle position (e). 
Low HAL treatment significantly increased air travel (F(2,13)=3.87, P<0.05) (f), although a second analysis 
of the change between HAL and LA-vehicle group suggests this effect may be due to LA. Friedman’s 
critical difference value (CDF)=10.81. Vertical bar values represent the mean±SD. P-values represent the 
post-hoc results. 
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Fig 5.1 Conditioning effects of repeated trials across groups in Experiment 2 HAL treatment 
resulted in improved performance in some tasks measured by a decrease from Pre-treatment control 
measures (Pre) and Post-treatment control measures (Post). In general, frogs showed improvement in 
behaviors directed toward exiting the arena to result in decreased trial time (a) and in exiting water (b). 
However, neither total time in water (c) nor climbing movement (d) showed significant conditioning 
effects. Vertical bar values represent the mean±SD. P-values represent significant differences in the 
paired t-test. 
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Fig 5.2 Conditioning effects of repeated trials across groups in Experiment 2 HAL treatment 
resulted in improved performance in some tasks measured by a decrease from Pre-treatment control 
measures (Pre) and Post-treatment control measures (Post). The time spent in a vertical settle position in 
water significantly decreased in the Post-treatment measures across all subjects (e). Although time in 
vertical settle position (f) and horizontal settle position (g) did not differ significantly, air travel increased 
significantly in the Post-treatment measures (h). Vertical bar values represent the mean±SD. P-values 
represent significant differences in the paired t-test. 
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 3  DISCUSSION 
 
The neuroanatomical conservation of DA systems across species supports the significance of DA 
in vertebrate behavior, however whether and how such behaviors are related at the functional 
level is largely undetermined, especially in non-mammalian systems. The aim of the current 
experiments was to examine the role of DA in a complex motor task by manipulating D2 
receptor activity in the anuran amphibian green tree frog, H. cinerea. Based on DA receptor 
mechanisms, it was predicted the D2 receptor agonist, quinpirole (QUIN), would decrease motor 
behaviors, and the D2 receptor antagonist, haloperidol (HAL), would increase motor behaviors if 
anuran basal ganglia function similarly to amniote basal ganglia. Understanding the behavioral 
effects of DA receptor-specific drugs in anurans contributes to our knowledge of DA modulation 
in behaviors of different vertebrate species.  
 
In general, the results meet the predicted outcome, in that QUIN tended to inhibit some 
behaviors, and HAL tended to facilitate some behaviors. For example, frogs that received the 
high QUIN dose spent more time in water compared to the low QUIN dose and control measures 
(Fig 2b), while frogs that received either HAL dose spent less time in water compared to the 
control (Fig 4b). Treatment with high QUIN dose increased time spent in a vertical settle 
position (Fig 2d), while treatment with HAL specifically decreased time to climb out of water 
(Fig 4d), and had no effect on the total amount of time in a vertical settle position (Fig 4e). The 
high QUIN treatment resulted in less air travel (hops and jumps) than the low QUIN or control 
treatments (Fig 2f). Although behavioral testing suggested HAL increased air travel, analysis of 
the vehicle-treated group suggested that this effect, in particular, may be due to lactic acid in the 
HAL solution. Overall, motor behaviors were not completely impaired following any treatments, 
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in that all frogs were able to swim to and climb to the top of the bricks following all drug or 
vehicle treatments. These experiments reveal treatment-specific behavioral effects that support 
D2 receptor signaling in motor processes of anurans, although other factors may also influence 
behavior expression. Notably the dose differences with QUIN treatment and similar effects with 
either HAL treatment support specificity of QUIN to the D2 receptor and a more variable effect 
of HAL on different neurotransmitter receptors. 
 
 
3.1 Inhibitory effects of D2 receptor agonist 
The prediction of opposite effects of the D2 receptor-specific treatments was based on previous 
behavioral and molecular data focused on DA receptors. In the field, QUIN treatment inhibited 
calling behavior of H. cinerea (Creighton et al., 2013). On similar lines, both IP and IV 
administration of QUIN inhibits sexual behaviors in quail (Kleitz-Nelson et al., 2010) (Balthazart 
et al., 1997) and mammals (reviewed in Hull, 2006), and aggressive behaviors for mate 
competition in zebra finches (Kabelik et al., 2010). It is noted that none of these experiments 
show impairment of movement per se, but rather a decrease in production of the behavior of 
focus. However, inconsistent effects of QUIN on locomotor behaviors in rodents confound the 
interpretation of what may be taking place. For example, QUIN increased general locomotor 
behaviors in rats (Stuchlik et al., 2007) and mice (Jung and Shim, 2011). However, Schindler et 
al. and Starke et al., using a lower dose, presented data for the opposite effect of QUIN 
treatment, in that it reduced locomotor behaviors (Schindler and Cannona, 2002) (Starke et al., 
1989). In fact, a biphasic effect is often seen following QUIN treatments in mammals, with 
locomotor behaviors decreasing for the first 5-15 minutes and increasing after 35 minutes 
(Horvitz et al., 2001) (Eilam and Szechtman, 1989) (Jesus Luque-Rojas et al., 2013) (Van 
Hartesveldt et al., 1992). Overall the mammalian data suggest different processes that involve 
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DA receptors may be acting to produce locomotor and goal-directed behaviors in the mammalian 
nervous system than in either the avian or anuran systems, where QUIN generally inhibits 
behaviors. It is already accepted that the avian nervous system contains more D2 receptors than 
D1 receptors (Kubikova et al., 2010) (Richfield et al., 1987), which may produce more consistent 
behavioral results following receptor-specific treatments, while the mammalian nervous system 
may be more susceptible to individual variation in D2 expression. Future work should identify 
and localize DA receptors in anuran tissue before confirming qualitative differences in DA 
receptors that could explain variances in the behavioral effects of QUIN treatment when 
compared with mammals.  
Field data on H. cinerea suggest QUIN may inhibit motivated behaviors, i.e. behaviors that are 
expressed for an intended goal. Anuran males produce advertisement calls to attract females 
during the mating season. Based on a generally low success rate and an increased risk of 
predation, one may question what is behind the strong innate drive to exhibit a costly behavior, 
such as calling, when the likelihood of an immediate reward is low. We found that active male 
green tree frogs treated with 5µg or 50µg of QUIN cease to exhibit any calling behaviors 
(Creighton et al., 2013). The present behavioral data suggest this inhibition of calling is not due 
to a general inhibitory effect of the drug on the motor system because frogs showed no 
differences in performance of some motor behaviors on control days and QUIN treatment days 
(e.g. swimming). However, behaviors that were affected by QUIN suggest a decreased drive to 
escape unpleasant conditions, thus spending more time in water even though this species is land-
oriented as adult. Together these behavioral data support that DA acts in the production of 
effortful behaviors, such as calling and climbing out of water, in H. cinerea.  
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3.2 Excitatory effects of D2 receptor antagonist not present 
The prediction of hyperactivity in motor behaviors was not seen following D2 receptor 
antagonist treatment, although frogs exited water faster on HAL treatment days compared to 
control treatment days. In fact, HAL often causes catalepsy, or muscle rigidity and freezing, in 
mammals at doses (by bodyweight) only slightly higher than those used in this study (Boulay et 
al., 2000) (Huang et al., 2010) (Salamone et al., 1991). The current behavioral measurements do 
not suggest HAL induced a cataleptic-like response in frogs. However, body-freezing and tonic, 
rigid movements similar to catalepsy can be induced in frogs by a HAL metabolite, CPPO, 
although the behavioral effects are not reliably visible until at least 2 days after IP treatment 
(Ablordeppey et al., 1992). The differences in the occurrence of catalepsy following HAL 
treatment, along with the differences in the effects of QUIN on locomotor behaviors, between 
anurans and mammals suggest dissimilarities in D2 receptor sensitivity, or DA system in general, 
between these classes of vertebrates.  
 
Retesting anurans with a greater range of HAL doses may produce results that clarify what is 
occurring at the receptor level to produce the behavioral differences compared to mammals. 
While the selected doses were presumed to be low on mammalian standards, if the anuran D2 
receptor is overly sensitive to HAL, then even the low dose used here could have a saturation 
effect. Also if multiple types of anuran receptors are sensitive to HAL, then many systems could 
be affected by IP treatment, causing a non-specific, generalized effect. Considering there was no 
dose effect, a greater range of doses may reveal HAL-sensitive receptor properties either unique 
to anurans or masked in anurans by oversaturation in the synapse by the current doses. It is worth 
noting very few published experiments using HAL have examined the impact of the acidic disso-
lvent in the HAL treatments compared to a saline-based control treatment. The finding that lactic 
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acid alone enhanced air travel behaviors questions the extent of HAL acting molecularly, rather 
than the dissolvent solution, to produce the behavioral effects in other experiments using this 
combination as treatment. Also what does it say about the anuran system to respond to LA with 
behavioral changes? One explanation may be based on the ability of anurans to adapt to different 
environments, and as a survival mechanism, their bodies are responsive to potentially dangerous 
substances found in the wild, such as LA. Thus, the increase in air time would be an indirect 
escape mechanism automatically triggered by the presence of LA in the body. Research needs to 
determine where LA is acting in anurans before its behavioral impact can be explained. 
  
3.3 Conditioning effects and performance improvement followed both treatments 
Behavioral conditioning is a term that refers to improvement of behavior performance, and the 
conditioning effect refers to the level of improvement that occurs with trial repetition. Both 
QUIN and HAL treatments resulted in a significant decrease in trial time for Post-treatment 
control compared to Pre-treatment control, suggesting the conditioning effect of repeated trials 
still took place even in the presence of drugs acting on D2 receptors in different ways. Other tests 
have shown anurans exhibit instrumental conditioning effects in a goal task without drug 
treatment, although conditioning effects are not quite the same as those of mammals and birds 
(Bilbo et al., 2000) (Muzio et al., 1992). However, it is striking that a conditioning effect was not 
present in the control group alone for Experiment 2, even though it is seen in the vehicle group 
that received LA on intermediate test days. More behavioral testing with a larger sample size 
focused on the number of trials necessary for performance improvement to appear may better 
explain what is taking place in the control group. 
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A second result from Experiment 2 that contradicts mammalian data is the presence of a 
conditioning effect following D2 antagonist treatment. Evidence from rats demonstrates D2 
antagonists prevent the development of conditioned place preference (Tzschentke, 1998) (Wright 
et al., 2013) and instrumental incentive learning (Dickinson et al., 2000). One hypothesis for 
these differences in results between anurans and mammals is that the level of D2 receptors 
responsive to antagonist treatment is altered in anurans compared to mammals. Differences in the 
effects of D2 receptor inhibition could be due to a lower total quantity of receptors or a 
decreased efficacy of the drug in anuran tissue compared to mammalian tissue. Also mammals 
have more neural tissue with DA receptors in general, and particularly in regard to cortical tissue 
in the forebrain. The presence of DA receptors in cortical tissue allows for potential synaptic 
connections that could influence mammalian behavior, but such cortical connections do not exist 
in the anuran brain. However non-cortical areas that process DA are also involved in behavioral 
conditioning in mammals. DA receptor density and localization need to be determined in anuran 
neural tissue to confirm what is taking place at the functional level to result in task performance 
improvement. In any case, the conditioning process differs to some extent between mammals and 
anurans. 
 
The basal ganglia direct and indirect pathways are significant in motor signaling and movement 
execution in mammals. Nishizawa et al. showed that elimination of the indirect striatopallidal 
pathway signaling specifically reduced motor accuracy with no effect on response time in an 
auditory conditioning task (Nishizawa et al., 2012), while Fukabori et al. revealed that direct 
striatonigral pathway lesioning impairs response time with no effects on motor accuracy 
(Fukabori et al., 2012). Finally Durieux et al. selectively damaged D2 receptor-expressing 
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medium spiny neurons, which resulted in overall diminished performance on a rotarod task 
(Durieux et al., 2009). However, in all cases, behavior performance of the test animals improved 
to control levels with repeated trials. The effect of performance improvement across trials when 
lacking at least one functional dorsal striatal pathway suggests the D2 receptor is not a 
determining factor for effective behavioral conditioning. Data from the current experiments 
support this suggestion by demonstrating the presence of conditioning effects from repeated 
trials while using treatments affecting the D2 receptors in opposing ways, i.e. both QUIN and 
HAL treatments resulted in behaviors that improved between the Pre-treatment control and Post-
treatment control measures.  
 
However, whether the behaviors that exhibited significant changes are considered “rewarding” 
from a frog perspective, and function through processes similar those in the mammalian 
mesolimbic reward pathway remains undetermined. Based on differences in neuroanatomical 
populations and striatal pathways in anuran neural tissue, it is possible the conditioning effects 
exhibited by frogs in these experiments may be through habit learning, which is not necessarily 
as dependent on DA as incentive-based learning (Berridge, 2007). Other behavioral evidence on 
water-deprived toads (Chaunus arenarum, formerly known as Bufo arenarum) supports the 
possibility of a different learning process based on habit formation, rather than behavior sensitive 
to incentive-based reward. Water-deprived toads conditioned in a runway task to obtain a water 
reward do not show similar conditioning effects as exhibited by mammals. In particular, toads 
show impairments in acquisition of a task, but not extinction, when receiving only partial 
reinforcement, while continuous reinforcement results in better acquisition of the task with 
reward and faster extinction when the training reward was large. However, rats show 
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impairments in extinction when conditioned on a partial-reward schedule or trained with a small 
reward (Muzio et al., 1992). Behavioral effects similar to anurans are also exhibited by goldfish 
(reviewed in Muzio et al., 1992). These results suggest anurans learn through habit formation 
and not by incentive value, which relies on DA in the mesolimbic system (Berridge and 
Robinson, 1998) (Muzio et al., 2011). For example in toads, adjustment to behaviors to obtain a 
reward, as well as reward intake, are based on previous reward size (Papini et al., 1995). This 
suggests habit formation because the behavior response in extinction is strongly related to the 
reward size during acquisition (Muzio et al., 2011). Together these differences in behavior 
support the possibility of another process that may be occurring to result in performance 
improvement in anurans that does not involve the DA systems.  
 
It is noted that other work on anurans has shown conditioning effects in a swimming task in the 
northern leopard frog (Lithobates pipiens) following anticholinergic treatment (Bilbo et al., 
2000). In particular, the anticholinergic treatment, atropine sulfate, impaired the ability of frogs 
to use a visual cue to locate the target stand in a dose-dependent pattern compared to control 
treatment. These results suggest acetylcholinergic systems are more strongly involved in the 
behavioral conditioning process of frogs than DA systems. The anuran acetylcholinergic system 
shows general similarities in cell populations in the basal forebrain when compared to amniotes, 
although notably different from other anamniote systems (Gonzalez et al., 2002). When 
considering the differences in neuroanatomy of the anuran basal ganglia system, it is possible 
that acetylcholine (ACh) has a greater role in behavior because anurans may not share the same 
functional disinhibitory basal ganglia system modulated by DA and ACh as accepted for 
amniotes. Although research has shown ChAT-ir neurons in the anuran forebrain (Marin et al., 
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1997c), more testing needs to be conducted to determine if there is any interaction between ACh 
and DA, such as DA receptor colocalization with ACh neurons. 
 
4  CONCLUSION 
The amniote striatum receives DA signals from the substantia nigra pars compacta, and relies on 
a functional balance between D1 and D2 receptors for accurate motor production (Choi et al., 
2009) (Robertson et al., 1992). There is also a large amount of glutamatergic input to the 
striatum from cortical areas involved in sensory and motor processing in the amniote brain 
(Yelnik, 2002) (Groenewegen, 2003). Evidence supports the presence of DA receptor-specific 
populations in the amphibian striatum (Marin et al., 1998b), and a dorsal striatopallidal pathway 
in anurans (Endepols et al., 2004b). However the anuran brain does not show the complexity of 
connections and feedback circuits with cortical tissue that produce behavioral signaling in 
mammals. How can receptor-specific drugs cause comparable behavioral effects in neural 
systems that differ in circuit complexity, such as in the mammalian and amphibian brains? To 
answer this question, we need to consider the significance of the conserved features in the 
vertebrate nervous system, and the processes that produce behaviors. While receptor localization 
is unknown in the anuran brain, data from Experiments 1 and 2 support functional conservation 
of DA systems and basal ganglia motor pathways in the production and improvement of 
behaviors without cortical input. Also the presence of conditioning effects following either D2 
agonist or antagonist treatment suggests DA may not play as significant a role in learning in 
anurans as in mammals. In fact, research on toads supports anuran learning processes are limited 
to habit formation, and do not extend to the generation of incentive value of a reward, as 
expressed by mammals (Muzio et al., 2011). In conclusion, H. cinerea serves as a useful model 
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for investigating the role of DA in regulating motor behavior because anurans lack executive 
processing that can complicate interpretation of pharmacological manipulations. The results from 
the current experiments support conservation of DA processes in behavior across vertebrate 
species, although future research is needed to determine the distribution of DA receptors in 
anuran neural tissue. 
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